Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

High prevalence of occult hepatitis B infection (OBI) among healthy children and their parents in Alborz province, Iran; Vertical OBI, myth or truth?

Ghaziasadi A, Fakhari Z, Aghcheli B, Poortahmasebi V, Farahmand M, Norouzi M, Ghalichi L, Soleimani A, Hedayat Yaghoobi M, Ravanshad M, Jazayeri SM.

Liver Int. 2019 Sep 13. doi: 10.1111/liv.14252. [Epub ahead of print]

PMID:
31518482
2.

Human papilloma virus (HPV) genotypes concordance between Iranian couples referrals.

Davarmanesh M, Dezfulian M, Gharavi MJ, Younesi S, Saadati P, Amin MMT, Jazayeri SM.

Infect Agent Cancer. 2019 Sep 9;14:22. doi: 10.1186/s13027-019-0241-x. eCollection 2019.

3.

Effect of inulin-type fructans in patients undergoing cancer treatments: A systematic review.

Mazraeh R, Azizi-Soleiman F, Jazayeri SMHM, Noori SMA.

Pak J Med Sci. 2019 Mar-Apr;35(2):575-580. doi: 10.12669/pjms.35.2.701. Review.

4.

Measurement of serum hepatitis B surface antibody levels in Iranian autistic children and evaluation of immunological memory after booster dose injection in comparison with controls.

Barfi S, Narges C, Pouretemad HR, Poortahmasebi V, Norouzi M, Farahmand M, Yahyapour Y, Ghorbani S, Ghalichi L, Ofoghi H, Jazayeri SM.

J Med Virol. 2019 Jul;91(7):1272-1278. doi: 10.1002/jmv.25429. Epub 2019 Feb 27.

PMID:
30761573
5.

Molecular evolution and phylodynamics of hepatitis B virus infection circulating in Iran.

Mozhgani SH, Malekpour SA, Norouzi M, Ramezani F, Rezaee SA, Poortahmasebi V, Sadeghi M, Alavian SM, Zarei-Ghobadi M, Ghaziasadi A, Karimzadeh H, Malekzadeh R, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Jahantigh HR, Somi MH, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Keyvani H, Kalantari E, Fakhari Z, Geravand B, Jazayeri SM.

Arch Virol. 2018 Jun;163(6):1479-1488. doi: 10.1007/s00705-018-3764-3. Epub 2018 Feb 13.

PMID:
29442226
6.

Human T-lymphotropic virus 1 (HTLV-1) pathogenesis: A systems virology study.

Mozhgani SH, Zarei-Ghobadi M, Teymoori-Rad M, Mokhtari-Azad T, Mirzaie M, Sheikhi M, Jazayeri SM, Shahbahrami R, Ghourchian H, Jafari M, Rezaee SA, Norouzi M.

J Cell Biochem. 2018 May;119(5):3968-3979. doi: 10.1002/jcb.26546. Epub 2018 Jan 19.

PMID:
29227540
7.

CRF35-AD as the Main Circulating Genotype of Human Immunodeficiency Virus Type 1 Infection in Iran: A Phylogenetic and Demographic-Based Study.

Mozhgani SH, Ebrahimian SA, Gudarzi H, Jazayeri SM, Jahanbakhsh F, Mohraz M, Rezaee SA, Azadmanesh K, Soltani S, Norouzi M.

Intervirology. 2017;60(4):144-148. doi: 10.1159/000484691. Epub 2017 Nov 30.

8.

Asymptomatic Epstein-Barr Virus Shedding in the Urine of Kidney Transplant Recipients: Case Reports and Review of the Literature.

Rahbar M, Poormand G, Mahmoodi MK, Jazayeri A, Jazayeri SM.

Infect Dis Rep. 2016 Dec 31;8(4):6817. doi: 10.4081/idr.2016.6817. eCollection 2016 Dec 31.

9.

Regulatory network analysis of Epstein-Barr virus identifies functional modules and hub genes involved in infectious mononucleosis.

Poorebrahim M, Salarian A, Najafi S, Abazari MF, Aleagha MN, Dadras MN, Jazayeri SM, Ataei A, Poortahmasebi V.

Arch Virol. 2017 May;162(5):1299-1309. doi: 10.1007/s00705-017-3242-3. Epub 2017 Feb 2.

PMID:
28155194
10.

Sero-Prevalence of Bloodborne Tumor Viruses (HCV, HBV, HTLV-I and KSHV Infections) and Related Risk Factors among Prisoners in Razavi Khorasan Province, Iran, in 2008.

Khajedaluee M, Babaei A, Vakili R, Valizade N, Homaei Shandiz F, Alavian SM, Seyed Nozadi M, Jazayeri SM, Hassannia T.

Hepat Mon. 2016 Dec 3;16(12):e31541. doi: 10.5812/hepatmon.31541. eCollection 2016 Dec.

11.

Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.

Mozhgani SH, Jaberi N, Rezaee SA, Bustani R, Jazayeri SM, Akbarin MM, Milani S, Tarokhian H, Norouzi M.

J Med Virol. 2017 Jun;89(6):1102-1107. doi: 10.1002/jmv.24721. Epub 2016 Nov 10.

PMID:
27787900
12.

Prevalence of Cytomegalovirus in Patients With Multiple Sclerosis: A Case-Control Study in Northern Iran.

Najafi S, Ghane M, Poortahmasebi V, Jazayeri SM, Yousefzadeh-Chabok S.

Jundishapur J Microbiol. 2016 Jul 3;9(7):e36582. doi: 10.5812/jjm.36582. eCollection 2016 Jul.

13.

Mutational analysis of reverse transcriptase and surface proteins of patients with partial virological response during mono and combination antiviral therapies in genotype D chronic hepatitis B.

Mahabadi M, Alavian SM, Norouzi M, Keyvani H, Mahmoudi M, Jazayeri SM.

Electron Physician. 2016 Jun 25;8(6):2466-74. doi: 10.19082/2466. eCollection 2016 Jun.

14.

HBsAg mutations related to occult hepatitis B virus infection in HIV-positive patients result in a reduced secretion and conformational changes of HBsAg.

Sadeghi A, Shirvani-Dastgerdi E, Tacke F, Yagmur E, Poortahmasebi V, Poorebrahim M, Mohraz M, Hajabdolbaghi M, Rasoolinejad M, Abbasian L, Jafari R, Fakhari Z, Norouzi M, Ebrahimian A, Geravand B, Alavian SM, Jazayeri SM.

J Med Virol. 2017 Feb;89(2):246-256. doi: 10.1002/jmv.24623. Epub 2016 Aug 1.

PMID:
27381922
15.

How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study.

Poortahmasebi V, Poorebrahim M, Najafi S, Jazayeri SM, Alavian SM, Arab SS, Ghavami S, Alavian SE, Rezaei Moghadam A, Amiri M.

Hepat Mon. 2016 Feb 20;16(2):e36005. doi: 10.5812/hepatmon.36005. eCollection 2016 Feb.

16.

IL-17 and IL-22 genetic polymorphisms in HBV vaccine non- and low-responders among healthcare workers.

Borzooy Z, Streinu-Cercel A, Mirshafiey A, Khamseh A, Mahmoudie MK, Navabi SS, Nosrati M, Najafi Z, Hosseini M, Jazayeri SM.

Germs. 2016 Mar 1;6(1):14-20. doi: 10.11599/germs.2016.1084. eCollection 2016 Mar.

17.

Identification of occult hepatitis B virus (HBV) infection and viral antigens in healthcare workers who presented low to moderate levels of anti-HBs after HBV vaccination.

Borzooy Z, Jazayeri SM, Mirshafiey A, Khamseh A, Mahmoudie MK, Azimzadeh P, Geravand B, Boroumand MA, Afshar M, Poortahmasebi V, Hosseini M, Streinu-Cercel A.

Germs. 2015 Dec 2;5(4):134-40. doi: 10.11599/germs.2015.1081. eCollection 2015 Dec.

18.

Evolution of hepatitis B virus surface gene and protein among Iranian chronic carriers from different provinces.

Ramezani F, Alavian SM, Sadeghi A, Khedive A, Ghalichi L, Norouzi M, Karimzadeh H, Malekzadeh R, Montazeri G, Nejatizadeh A, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Somi MH, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Rafatpanah H, Keyvani H, Kalantari E, Saberfiroozi M, Rezaee R, Daram M, Mahabadi M, Goodarzi Z, Poortahmasebi V, Geravand B, Khamseh A, Mahmoodi M, Jazayeri SM.

Iran J Microbiol. 2015 Aug;7(4):214-20.

19.

Appropriate Genotyping of Hepatitis B Virus in Iran.

Jazayeri SM, Sharafi H, Alavian SM.

Jundishapur J Microbiol. 2015 Oct 17;8(10):e23529. doi: 10.5812/jjm.23529. eCollection 2015 Oct. No abstract available.

20.

Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical Features.

Poortahmasebi V, Malekzadeh R, Montazeri G, Fakhari E, Norouzi M, Khamseh A, Mahmoodi Karkhaneh M, Tavakoli A, Jazayeri SM.

Jundishapur J Microbiol. 2015 Sep 12;8(9):e20262. doi: 10.5812/jjm.20262. eCollection 2015 Sep.

21.

Prevalence of blood-borne viruses among Iranian dentists: Results of a national survey.

Ahmad Akhoundi MS, Momeni N, Norouzi M, Ghalichi L, Shamshiri AR, Alavian SM, Poortahmasebi V, Jazayeri SM.

Int J Occup Med Environ Health. 2015;28(3):593-602. doi: 10.13075/ijomeh.1896.00324.

22.

Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis Study.

Rezaee R, Aghcheli B, Poortahmasebi V, Qorbani M, Alavian SM, Jazayeri SM.

Hepat Mon. 2015 Apr 25;15(5):e23618. doi: 10.5812/hepatmon.15(04)2015.23618. eCollection 2015 May. Review.

23.

HBV vaccination status and response to hepatitis B vaccine among Iranian dentists, correlation with risk factors and preventive measures.

Momeni N, Ahmad Akhoundi MS, Alavian SM, Shamshiri AR, Norouzi M, Mahboobi N, Moosavi N, Jazayeri SM.

Hepat Mon. 2014 Dec 27;15(1):e20014. doi: 10.5812/hepatmon.20014. eCollection 2015 Jan.

24.

Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy.

Daram M, Montazeri G, Karimzadeh H, Malekzadeh R, Mahmoodi M, Goodarzi Z, Keyvani H, Mirmomen S, Alavian SM, Roggendorf M, Jazayeri SM.

Iran J Basic Med Sci. 2014 Sep;17(9):638-45.

25.

The pigeonhole of occult hepatitis B.

Dindoost P, Chimeh N, Hollinger BF, Saberfar E, Norouzi M, Jazayeri SM.

Acta Med Iran. 2014;52(8):582-90. Review.

26.

Characterization of overt and occult hepatitis B virus infection among HTLV-1 positive healthy carriers in the Northeast of Iran; AN HTLV-I endemic area.

Chenari M, Norouzi M, Ghalichi L, Rezaee A, Yari A, Alavian SM, Jazayeri SM.

J Med Virol. 2014 Nov;86(11):1861-7. doi: 10.1002/jmv.24046. Epub 2014 Aug 13.

PMID:
25132488
27.

Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infection.

Poortahmasebi V, Alavian SM, Keyvani H, Norouzi M, Mahmoodi M, Jazayeri SM.

Asian Pac J Cancer Prev. 2014;15(9):3879-84.

28.

Prevalence and molecular analysis of occult hepatitis B virus infection isolated in a sample of cryptogenic cirrhosis patients in iran.

Anvari FA, Alavian SM, Norouzi M, Mahabadi M, Jazayeri SM.

Oman Med J. 2014 Mar;29(2):92-6. doi: 10.5001/omj.2014.23.

29.

Prospective study of BK virus infection and nephropathy during the first year after kidney transplantation.

Soleymanian T, Keyvani H, Jazayeri SM, Fazeli Z, Ghamari S, Mahabadi M, Chegeni V, Najafi I, Ganji MR.

Iran J Kidney Dis. 2014 Mar;8(2):145-51. Erratum in: Iran J Kidney Dis. 2014 May;8(3):260. Ganji, Mohammadreza [corrected to Ganji, Mohammad Reza].

30.

Prevalence of common YMDD motif mutations in long term treated chronic HBV infections in a Turkish population.

Alavian SM, Jazayeri SM.

Asian Pac J Cancer Prev. 2014;15(2):1065. No abstract available.

31.

Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients with unusual clinical pictures.

Ghamari S, Alavian SM, Rizzetto M, Olivero A, Smedile A, Khedive A, Alavian SE, Zolfaghari MR, Jazayeri SM.

Hepat Mon. 2013 Aug 16;13(8):e6731. doi: 10.5812/hepatmon.6731. eCollection 2013.

32.

Mutational analysis of HBs Ag-positive mothers and their infected children despite immunoprophylaxis.

Ghaziasadi A, Alavian SM, Norouzi M, Fazeli Z, Jazayeri SM.

Iran J Allergy Asthma Immunol. 2013 Aug 28;12(4):352-60.

33.

Mutation hot spots in hepatitis B surface antigen in chronic carriers from Khoozestan province, southern of Iran.

Ramezani F, Norouzi M, Sarizade GR, Poortahmasebi V, Kalantar E, Magnius L, Norder H, Domingo E, Jazayeri SM.

Iran J Allergy Asthma Immunol. 2013 Jul 13;12(3):269-75.

34.

Hepatitis B virus surface antigen (HBsAg) mutations are rare but clustered in immune epitopes in chronic carriers from Sistan-Balouchestan Province, Iran.

Khedive A, Sanei-Moghaddam I, Alavian SM, Saberfar E, Norouzi M, Judaki M, Ghamari S, Jazayeri SM.

Arch Iran Med. 2013 Jul;16(7):385-9. doi: 013167/AIM.005.

35.

Occult Hepatitis B (OBH) in Clinical Settings.

Alavian SM, Miri SM, Hollinger FB, Jazayeri SM.

Hepat Mon. 2012 Aug;12(8):e6126. doi: 10.5812/hepatmon.6126. Epub 2012 Aug 25.

36.

HBsAg variants: diagnostic-escape and diagnostic dilemma.

Alavian SM, Carman WF, Jazayeri SM.

J Clin Virol. 2013 Jul;57(3):201-8. doi: 10.1016/j.jcv.2012.04.027. Epub 2012 Jul 11. Review.

PMID:
22789139
37.

Comparing the efficacy of intra-articular application of morphine and tramadol on postoperative pain after arthroscopic knee surgery.

Jazayeri SM, Mosaffa F, Abbasian M, Hosseinzadeh HR.

Anesth Pain Med. 2012 Summer;2(1):28-31. doi: 10.5812/aapm.4815. Epub 2012 Jul 10.

38.

High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG.

Shahmoradi S, Yahyapour Y, Mahmoodi M, Alavian SM, Fazeli Z, Jazayeri SM.

J Hepatol. 2012 Sep;57(3):515-21. doi: 10.1016/j.jhep.2012.04.021. Epub 2012 May 19.

PMID:
22617152
39.

The prevalence of hepatitis B virus surface antigen (HBsAg) variations and correlation with the clinical and serologic pictures in chronic carriers from Khorasan Province, North-East of Iran.

Ghaziasadi A, Ziaee M, Norouzi M, Malekzadeh R, Alavian SM, Saberfar E, Judaki MA, Ghamari S, Khedive A, Namazi A, Rahimnia R, Jazayeri SM.

Acta Med Iran. 2012;50(4):265-72.

40.

Hepatitis B immune globulin in liver transplantation prophylaxis: an update.

Dindoost P, Jazayeri SM, Alavian SM.

Hepat Mon. 2012 Mar;12(3):168-76. doi: 10.5812/hepatmon.832. Epub 2012 Mar 28.

41.

Hepatitis B virus variants in HBV mono-infected versus HBV/HIV co-infected patients.

Jazayeri SM, Alavian SM.

Curr HIV Res. 2012 Apr;10(3):245-6. No abstract available.

PMID:
22497696
42.

Commentary on "risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States".

Alavian SM, Jazayeri SM.

Am J Gastroenterol. 2012 Apr;107(4):635. doi: 10.1038/ajg.2012.22. No abstract available.

PMID:
22475970
44.

Other views of occult hepatitis B in Hepatitis C infected patients.

Alavian SM, Jazayeri SM.

Eur J Intern Med. 2011 Oct;22(5):e67-8. doi: 10.1016/j.ejim.2011.05.003. Epub 2011 Jun 1. No abstract available.

PMID:
21925047
45.

YMDD motif mutation after lamivudine therapy.

Jazayeri SM, Miri SM, Alavian SM.

Asian J Transfus Sci. 2011 Jul;5(2):178-9. doi: 10.4103/0973-6247.83252. No abstract available.

46.

Hepatitis B genotypes distribution in South Asia and Middle East.

Jazayeri SM, Miri SM, Alavian SM.

Infect Genet Evol. 2011 Aug;11(6):1193-4. doi: 10.1016/j.meegid.2011.04.032. Epub 2011 May 11. No abstract available.

PMID:
21600304
47.

Differential reactivity of mouse monoclonal anti-HBs antibodies with recombinant mutant HBs antigens.

Roohi A, Yazdani Y, Khoshnoodi J, Jazayeri SM, Carman WF, Chamankhah M, Rashedan M, Shokri F.

World J Gastroenterol. 2006 Sep 7;12(33):5368-74.

Supplemental Content

Loading ...
Support Center